Smoking prevalence among Africans at workplace :
Socio
demographic inequalities and cardiovascular
risk.12th world
conference on Tobacco or health.3-8 august 2003, Helsinki,
Finland: 62(abstract).
43. MCKEE PA, CASTELLI WP, MCNAMARA PM,KANNEL
WM.
The natural history of congestive heart failure : the
Framingham heart study.
N Engl J Med 1971; 285: 1441-46.
44. ERIKSON H, SVÄRDSUDD K, LARSSON B et
al.
Risk factors for heart failure in the general population : the
study of men born in 1913.
Eur Heart J 1989; 10: 647-56.
45. LEVY D, LARSON MG, VASAN RS, KANNEL WB, HO
KKL.
The progression from hypertension to congestive heart
failure.
JAMA 1996; 275 :1557-62.
46. ABENGOWE CU.
Cardiovascular disease in Northern Nigeria.Trop geogr
Med 1979 ; 31(4) : 553-60.
47. JULIEN G, FRABOULET JY, PONCELET PETAL.
Registre de l'insuffisance cardiaque en cardiologie
libérale.
Arch Mal Coeur 2001 ;94 :1351-6.
48. REMME WJ, SWEDBERG K.
Guidelines for the diagnosis and treatment of chronic
heart
failure.
Eur Heart J 2001;22: 1527-60.
49. COHEN-SOLAL A, DESNOS M, DELAHAYE F, EMERIAU
JP,HANANIA GA.
National survey of heart failure in French hospitals.
Rev Prat 2002; 21: 763-9.
50. DONNISON CP.
Blood pressure in the African native: its
bearing upon the aetiology of hyperpression and arterial
sclerosis. Lancet 1929;1:6-7.
51. TICOLAT R, BERTRAND ED et
al.
Aspects épidémiologiques de la maladie coronaire
chez le Noir Africain : à propos de 103 cas. Résultats de
l'enquête multicentrique prospective coronafric.
Card Trop 1991; 17 : 7-20.
52. WONG TY, ROSAMOND W, CHANG PP, COUPER
DJ,
KLEIN R.
Retinopathy and Risk of congestive heart failure.
JAMA 2005; 293 (1) : 63-9.
53. MBARAGA NGABO.
Etude clinique de l'hypertension artérielle en milieu
hospitalier à Kinshasa. Mémoire de spécialisation,
université de Kinshasa, 1983.
54. ANDRE-FOUËT X.
L'examen physique. Cardiologie,
Presses Universitaires de Lyon,1999 :
153-77.
55. REMES J, LANSIMIES E, PYORALAK.
Usefulness of M-mode echocardiography in the diagnosis of
heart failure. Cardiology 1991;78:267-77.
56. M'BUYAMBA -KABANGU JR, FAGARD R, LIJNEN P,
STAESSEN J, DITU MS, TSHIANIKA, et al.
Epidemiological in a sample of urban Bantu of Zaïre.
J Hypertens 1986; 4 : 485 -91.
57. SCHENCK -GUSTAFSSON K.
Risk factors for cardiovascular disease in Women. Heart beat
Bulletin of the World Heart Federation,
S- 17176 Stockholm, Sweden, March 2000.
58. BEEVERS DG, PRINCE JS.
Hypertension : an emerging problem in tropical
countries.
Trans Royal Med Hy 1991 ;85 :324 - 26.
59. LONGO MBENZA B, BIELELI E, VANNGU N, DITU
MS.
The role of early hemodynamic impairment and
disease
duration on diabetic cardiomyopathy and hypertension
in
Central Africans with atherosclerosis.
J Diabetes complications2001;15:1-7.
60. NKONDI MBADI J
Prévalence et facteurs de risque de la
rétinopathie
diabétique à Kinshasa.
Mémoire de spécialisation, Université de
Kinshasa, 2005.
61. CHAE CU, ET AL.
1.5. Increased
pulse pressure and risk of heart failure in the elderly.
JAMA,1999; 281:634-9.
62. KANNEL WB, PINSKY JL.
Trends in cardiac failure incidence and causes of three
decades in the Framingham study.
J Am Coll Cardiol 1991;17 (Suppl A) : 87A-92 A.
63. OYATI IA, DANBAUCHI SS, ALHASSAN MA, I SA
MS.
Diastolic dysfunction in persons with hypertension
heart
Failure.
J Natl Med Assoc 2004 ; 96(7): 968-73).
64. NESSLER J, SKRZYPEK A, PIWOWARSKA W.
Diastolic dysfunction as a risk factor in patients with heart
failure.
Przegl lek 2004; 61(9): 962-7.
65. THE CONSENSUS TRIAL STUD GROUP.
Effects of enalapril on mortality in severe congestive heart
failure.
N Engl J Med 1987; 316 : 1429-35.
66. THOMAS GILES.
Enalapril in the treatment of Congestive Heart Failure.
J Cardiovas Pharmacol 1990 ; 15 (Suppl 3): S6 -S10.
69. PACKER M , LEE WH, YASHAK M, et
al.
Comparison of Captopril and Enalapril in patients with severe
chronic heart failure.
N Engl J Med 1986; 315 : 847-53.
70. DAGIANIT A, ARATA L, FEDELE F, et al.
Effects of acute administration of Enalapril on myocardial
metabolism and coronary hemodynamics.
Curr Ther Res 1987 ; 41 : 403-8.
71. MC GRATH BP, ARNOLDA L, MATTHEMS PG, et al
.
Controlled Trial of enalapril in Congestive Cardiac
failure.
Br Heart J 1985; 54 : 405-14.
72. CLELAND JG, DARGIE HJ. BALL SG, et al.
Effects of enalapril in heart failure : a double blind
Study of effects on exercise performance, renal function, hormones, and
metabolic Stase.
Br Heart J 1985; 54 : 305-12.
67. LEE DC, JONHSON RA, BINGHAM JB, et
al.
Heart failure in patients : A Randomized trial of digitalis
versus placebo.
N Engl J M 1982; 306 : 699- 705.
68. FLEG JL, GOTTLIERB SH, LAKA TTA EG.
Is digoxin really important in treatment of compensated heart
failure ?
A placebo -controlled cross over Study in patient with sinus
rythm.
A M J Med 1982; 73 : 244-50.
73. COHN JN, JOHNSON G, ZIESCHE S et al.
A comparison of enalapril with hydralazine, isosorbide
dinitrate in the treatment of chronic congestive heart failure.
N Engl J Med 1991; 325: 303-10.
74. PACKER M, O'CONNOR CM, GHALI JK et
al.
The prospective randomized amlodipine survival evaluation
study group. Effet of amlodipine on morbidity and mortality in severe chronic
heart failure.
N Engl J Med 1996; 335: 110-14.
75. COHN JN, ZIESCHES, SMITH R et al.
For the vasodilator heart failure trial study group. Effet of
the calcium antagonist felodipine as supplementary vasodilatator therapy in
patients with chronic heart failure treated with enalapril. Circulation 1997;
96: 856-63.
76. YANCY CW.
Special Clinical Considerations of beta-blocker treatment.
Rev Cardiovasc Med 2002; 3 (Suppl 3 ) : S 27 -35.
77. ABDULLA J.
Effet of the angiotensin converting enzyme inhibitor and
adjuvant beta-blocker therapy on functional class and exercice tolerance in
patients with heart failure and left ventricular systolic dysfunction.
Ugeskr Laeger 2006 ; 168 (3) : 295-305.
78. STEWART S, MACLNTYRE K, MACLEOD MMC, BAILEY
AEM ,CAPEWELLS, MC MURRAY JJV.
Trends in hospitalization for heart failure in
Scotland 1990-
1996.
Rev Prat 2001 ; 22 : 209-17.
79. SVENSSON C, HULTGREN J, OLTENACU PA.
Morbidity in 3-7- month -old dairy calves in South-Westen,
and risk factors for diarrhoea and respiratory disease.
Prev Vet Med 2006 ; (Epub ahead of print).
| 
